Congo to receive 70K doses of Ervebo Ebola vaccine used in past outbreaks
The Ervebo vaccine is licensed for use against Ebola virus, one of the viruses that cause Ebola disease, but not for Bundibugyo virus.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on globalnews.ca — the content belongs to Global News Health.
